Home / Neuroscience
Neuroscience

| 2 min read
Advanced Chemistry Development Inc., (ACD/Labs) recently announced that it has been collaborating with leading Alzheimer’s research scientist Dr. Gilbert Rishton, founder and director of the Channel Islands Alzheimer’s Institute at California State University, to evaluate central nervous system drugs and gain a deeper understanding of the parameters that effect blood-brain barrier permeability.





